These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

967 related items for PubMed ID: 8689882

  • 61. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K.
    Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
    [Abstract] [Full Text] [Related]

  • 62. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW, Holma P, Pyörälä T.
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [Abstract] [Full Text] [Related]

  • 63. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 64. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 65. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
    Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M.
    Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
    [Abstract] [Full Text] [Related]

  • 66. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
    Ruchhoft EA, Elkind-Hirsch KE, Malinak R.
    Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
    [Abstract] [Full Text] [Related]

  • 67. Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
    Hammond GL, Bocchinfuso WP, Orava M, Smith CL, van den Ende A, van Enk A.
    Contraception; 1994 Oct; 50(4):301-18. PubMed ID: 7813219
    [Abstract] [Full Text] [Related]

  • 68. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
    [Abstract] [Full Text] [Related]

  • 69. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [Abstract] [Full Text] [Related]

  • 70. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 71. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [Abstract] [Full Text] [Related]

  • 72. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood.
    Thijssen JH.
    Ann N Y Acad Sci; 1988 Mar; 538():280-6. PubMed ID: 3056190
    [Abstract] [Full Text] [Related]

  • 73. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 74. [Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
    Negri P, D'Errico G, Minisci N, Tomasi A.
    Minerva Ginecol; 1988 Dec; 40(12):699-707. PubMed ID: 2977429
    [Abstract] [Full Text] [Related]

  • 75. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U, Jung-Hoffmann C, Kuhl H.
    Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
    [Abstract] [Full Text] [Related]

  • 76. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
    Cullberg G, Samsioe G, Andersen RF, Bredesgaard P, Andersen NB, Ernerot H, Fanøe E, Fylling P, Haack-Sørensen PE, Klottrup P, Pedersen JH, Sandager T.
    Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
    [Abstract] [Full Text] [Related]

  • 77. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
    Brill K, Norpoth T, Schnitker J, Albring M.
    Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166
    [Abstract] [Full Text] [Related]

  • 78. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
    Breitkopf DM, Rosen MP, Young SL, Nagamani M.
    Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556
    [Abstract] [Full Text] [Related]

  • 79. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 80. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF, Timmer CJ, Lammers P.
    Fertil Steril; 1994 Apr 16; 61(4):645-51. PubMed ID: 8150105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.